Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -5.36% vs 6.48% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -79.33% vs 53.04% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -50.22% vs 43.47% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -2.86% vs -42.62% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Harbin Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -5.36% vs 6.48% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -1.20% vs 5.98% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -79.33% vs 53.04% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -73.84% vs 112.29% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -50.22% vs 43.47% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -42.03% vs 62.38% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -2.86% vs -42.62% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -23.88% vs 7.20% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






